Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7403	Dimethyloxaloylglycine(DMOG) Featured	DMOG is a cell permeable prolyl-4-hydroxylase inhibitor, which upregulates HIF (hypoxia-inducible factor).
DC9434	DMP 777	DMP 777(L-694458) is a potent, selective, and orally active human leukocyte elastase (HLE) inhibitor.
DC20600	DM-PIT-1 Featured	DM-PIT-1 is a specific PIP3 antagonist that disrupts PIP3/Akt PH domain, PIP3/PDK1 PH domain, and PIP3/GRP1 PH domain with IC50 of 27.1 uM, 80.5 uM, and 35.5 uM, respectively.
DC12079	DMU2105	DMU2105 is a potent and specific CYP1B1 inhibitor, with IC50s of 10, 742 nM for CYP1B1 and CYP1A1, respectively.
DC11473	DMU-2105(CYP1B1 inhibitor 7k) Featured	DMU-2105(CYP1B1 inhibitor 7k) is a potent and specific CYP1B1 inhibitor.
DC22291	DMU-212（resveratrol analog） Featured	DMU-212, a methoxylated resveratrol analog, has significant anticancer activity, and selectively targets tumor cells.
DC22307	DMX-5804 Featured	DMX-5804 is a potent, orally active and selective MAP4K4 inhibitor, with an IC50 of 3 nM, a pIC50 of 8.55 for human MAP4K4, less potent on MINK1/MAP4K6 (pIC50, 8.18), and TNIK/MAP4K7 (pIC50, 7.96).
DC7404	DMXAA Featured	DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM, respectively. Phase 3.
DC20959	DNDI-8219	DNDI-8219 is a novel potent, orally active antileishmanial agent with IC50 of 0.19 uM against Leishmania donovani (L. don).
DC23671	DNMDP	DNMDP is a potent and selective cancer cell cytotoxic agent that binds to PDE3A, promotes an interaction between PDE3A and Schlafen 12 (SLFN12).
DC11337	MMP Substrate II Control	Dnp-GPLG is a peptide for use as a negative control for activity of matrix metalloproteinases (MMPs) that cleave peptides containing the sequence Dnp-GPLG.
DC11342	MMP-1 Fluorogenic Substrate III	Dnp-P-Cha-Abu-Cys(Me)-HA-K(Nma)-NH2 is a fluorogenic substrate for matrix metalloproteinase-1 (MMP-1) and MMP-9.
DC11348	MMP-1/MMP-9 Fluorogenic Substrate Featured	Dnp-P-Cha-G-Cys(Me)-HA-K(Nma)-NH2 is a fluorogenic substrate for matrix metalloproteinase-1 (MMP-1) and MMP-9
DC11351	MMP-1 Fluorogenic Substrate I Featured	Dnp-PLALWAR is a fluorogenic substrate for matrix metalloproteinase-1 (MMP-1) and MMP-8.
DC11339	MMP-8/MMP-26 Fluorogenic Substrate Featured	Dnp-PLAYWAR is a fluorogenic substrate for matrix metalloproteinase-8 (MMP-8) and MMP-26.The activity of MMP-8 and MMP-26 can be quantified by measuring tryptophan fluorescence that is unquenched upon peptide hydrolysis that removes the N-terminal dinitro
DC11347	MMP-1 Substrate II Featured	Dnp-PLG-Cys(Me)-HA-DArg-NH2 is a peptide substrate for matrix metalloproteinase-1 (MMP-1).It has an improved kcat/Km ratio compared with the MMP-1 flurogenic substrate Dnp-PLGLWA-DArg-NH2.
DC11344	MMP-2/MMP-9 Fluorogenic Substrate I	Dnp-PLGMWSR is a fluorogenic substrate for matrix metalloproteinase-2 (MMP-2) and MMP-9.The activity of MMP-2 and MMP-9 can be quantified by measuring tryptophan fluorescence that is unquenched upon peptide hydrolysis that removes the N-terminal dinitroph
DC11345	MMP-7 Fluorogenic Substrate	Dnp-RPLALWRS is a fluorogenic substrate for matrix metalloproteinase-7 (MMP-7).The activity of MMP-7 can be quantified by measuring tryptophan fluorescence that is unquenched upon peptide hydrolysis that removes the N-terminal dinitrophenol (Dnp) group.
DC10673	DNQX disodium salt Featured	DNQX is a elective non-NMDA antagonist
DC10672	DNQX Featured	DNQX is a elective non-NMDA antagonist
DC21509	DNS-pE	DNS-pE (PHGDH Fluorescent Probe DNS-pE) is the first small molecule that can selectively label endogenous 3-phosphoglycerate dehydrogenase (PHGDH) from various mammalian cells.
DC20364	DNS-pE2	DNS-pE2 is the first small molecule that can selectively label endogenous 3-phosphoglycerate dehydrogenase (PHGDH) from various mammalian cells.
DC11464	DO-264 Featured	DO264 is an inhibitor of α/β-hydrolase domain-containing protein 12 (ABHD12; IC50 = 11 nM).It inhibits ABHD12-dependent hydrolysis of lysophosphatidylserine (lyso-PS) in mouse brain membrane lysates (IC50 = 2.8 nM) and human THP-1 cells.
DC20136	DO34 analog	DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.
DC20960	DO-34	DO-34 is a highly potent dual DAGLα/β inhibitor with IC50 of 6 nM 3-8 nM, respectively.
DC8416	Docetaxel Trihydrate	Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.
DC4187	Docetaxel Featured	Docetaxel, an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules.
DCAPI1299	Docosanol (Abreva)	Docosanol (Abreva)
DC12208	Docosapentaenoic acid 22n-3	Docosapentaenoic acid (22n-3) is a component of phospholipids found in all animal cell membranes.
DC10247	Docusate Sodium	Docusate Sodium is a laxative used to treat constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally.

Inhibitors & Agonists

Customized Consultation X

Your information is safe with us. * Required Fields.